We bring you the latest news from the healthcare about the health care in the United Kingdom.

donderdag 3 mei 2018

Oncogene - Table of Contents alert Volume 37 Issue 18

If you are unable to see the message below, click here to view.
Oncogene

TABLE OF CONTENTS

Volume 37, Issue 18

In this issue
Review Article
Article
Also new
AOP

Review Article

Nucleolus as an emerging hub in maintenance of genome stability and cancer pathogenesis

Mikael S. Lindström, Deana Jurada, Sladana Bursac, Ines Orsolic, Jiri Bartek et al.

Oncogene 2018 37 :2351 - 2366; February 12, 2018; 10.1038/s41388-017-0121-z

Abstract | Full Text

Metabolic features of cancer stem cells: the emerging role of lipid metabolism

Rita Mancini, Alessia Noto, Maria Elena Pisanu, Claudia De Vitis, Marcello Maugeri-Saccà et al.

Oncogene 2018 37 :2367 - 2378; February 15, 2018; 10.1038/s41388-018-0141-3

Abstract | Full Text

Article

p53 isoforms regulate premature aging in human cells

Natalia von Muhlinen, Izumi Horikawa, Fatima Alam, Kazunobu Isogaya, Delphine Lissa et al.

Oncogene 2018 37 :2379 - 2393; February 12, 2018; 10.1038/s41388-017-0101-3

Abstract | Full Text

SRSF10-mediated IL1RAP alternative splicing regulates cervical cancer oncogenesis via mIL1RAP-NF-κB-CD47 axis

Fei Liu, Miao Dai, Qinyang Xu, Xiaolu Zhu, Yang Zhou et al.

Oncogene 2018 37 :2394 - 2409; February 12, 2018; 10.1038/s41388-017-0119-6

Abstract | Full Text

Differential role of FL-BID and t-BID during verotoxin-1-induced apoptosis in Burkitt's lymphoma cells

Justine Debernardi, Emilie Hollville, Marc Lipinski, Joëlle Wiels & Aude Robert

Oncogene 2018 37 :2410 - 2421; February 14, 2018; 10.1038/s41388-018-0123-5

Abstract | Full Text

The deubiquitinase USP9X promotes tumor cell survival and confers chemoresistance through YAP1 stabilization

Lei Li, Tongzheng Liu, Yunhui Li, Chenming Wu, Kuntian Luo et al.

Oncogene 2018 37 :2422 - 2431; February 16, 2018; 10.1038/s41388-018-0134-2

Abstract | Full Text

Arresting of miR-186 and releasing of H19 by DDX43 facilitate tumorigenesis and CML progression

J. Lin, J.-C. Ma, J. Yang, J.-Y. Yin, X.-X. Chen et al.

Oncogene 2018 37 :2432 - 2443; February 16, 2018; 10.1038/s41388-018-0146-y

Abstract | Full Text

Heterogeneity and mutation in KRAS and associated oncogenes: evaluating the potential for the evolution of resistance to targeting of KRAS G12C

Vincent L. Cannataro, Stephen G. Gaffney, Carly Stender, Zi-Ming Zhao, Mark Philips et al.

Oncogene 2018 37 :2444 - 2455; February 16, 2018; 10.1038/s41388-017-0105-z

Abstract | Full Text

Tumor cell-intrinsic Tim-3 promotes liver cancer via NF-κB/IL-6/STAT3 axis

Hualin Zhang, Yang Song, Huimin Yang, Zhiyan Liu, Lifen Gao et al.

Oncogene 2018 37 :2456 - 2468; February 16, 2018; 10.1038/s41388-018-0140-4

Abstract | Full Text

Novel synthetic bisindolylmaleimide alkaloids inhibit STAT3 activation by binding to the SH2 domain and suppress breast xenograft tumor growth

Xia Li, Hongguang Ma, Lin Li, Yifan Chen, Xiao Sun et al.

Oncogene 2018 37 :2469 - 2480; February 19, 2018; 10.1038/s41388-017-0076-0

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature